ONWARD Medical appoints Tim Denison to Board of Directors, focusing on neurotechnology and therapy.

ONWARD Medical N.V. announces changes to its Board of Directors, with Professor Tim Denison joining and Professor Gregoire Courtine transitioning to Science Advisor. Denison brings expertise in neurotechnology from his role at Medtronic and as Chief Engineer at Amber Therapeutics. Courtine will focus on new responsibilities as Director of the Neuro-X Institute and at EPFL, continuing to support ONWARD as Science Advisor. The Neuro-X Institute is a Swiss neuroscience research hub working on next-gen therapies for neurological disorders. ONWARD is known for its ARC Therapy, with the ARC-EX System already cleared for commercial sale in the US.

Read more at GlobeNewswire: ONWARD Medical Adds Entrepreneur and Neurotechnology